Johnson & Johnson
JNJ- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000200406
In the last 90 days, Johnson & Johnson insiders filed 0 open-market purchases and 3 sales; 4,720 institutions reported holding it in 13F filings for Q2 2026, worth $457.0B in total; 5 superinvestors hold it, including Markel Group and Fairfax Financial.
Key figures
- Market capClose on Nov 10, 2026
- $675.9B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $45.4M in total
- 3
- 13F holdersQ2 2026, +102 vs. previous quarter
- 4,720
- 13F valueReported value at the end of Q2 2026
- $457.0B
- Superinvestors holdingAt the end of Q2 2026
- 5
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $94.2B
- +6.0% year over year
- Net income, FY2025
- $26.8B
- +90.6% year over year
- Free cash flow, FY2025
- $19.7B
- −0.7% year over year
- Revenue, Q3 FY2026
- $25.4B
- +5.9% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 17.1M
- Shares sold short
- Change
- +301.6K
- +1.8% vs. previous
- Days to cover
- 2.41
- At average daily volume
Superinvestors holding JNJ, Q2 2026
Go to the superinvestors tab5 superinvestors report holding Johnson & Johnson on Form 13F. Percentages are the stock's share of each portfolio.
| Superinvestor | Weight | Value |
|---|---|---|
| Soros Fund Management | 0.1% | $8.64M |
| Gardner Russo & Quinn | <0.1% | $282.4K |
| Semper Augustus | <0.1% | $201.7K |
Latest insider trades
See all insider tradesOpen-market purchases and sales by Johnson & Johnson insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 (view filing)9:08 AM ET | Sep 2 | 2 days | Schmid TimothyEVP, WW Chair, MedTech | SSale | −33.6K | $274.74 | −$9.23M | −56.9%25.4K after | 2 lots |
| Aug 18, 2026 (view filing)6:31 PM ET | Aug 17 | 1 day | Taubert Jennifer LEVP, WWC. Innovative Medicine | SSale | −15.0K | $263.36 | −$3.95M | −7.2%194.5K after | |
| Aug 14, 2026 (view filing)4:35 PM ET | Aug 13 | 1 day | Duato JoaquinCEO and Chairman of the Board | SSale | −123.3K | $261.17 | −$32.2M | −30.9%276.0K after | 2 lots |
| Aug 7, 2026 (view filing)5:50 PM ET | Aug 5 | 2 days | Duato JoaquinCEO and Chairman of the Board | SSale | −48.5K | $258.15 | −$12.5M | −14.9%276.0K after | 2 lots |
| Aug 7, 2026 (view filing)5:44 PM ET | Aug 6 | 1 day | Forminard ElizabethEVP, Chief Legal Officer | SSale | −15.9K | $257.00 | −$4.09M | −48.4%17.0K after | 2 lots |
| Jul 21, 2026 (view filing)5:27 PM ET | Jul 20 | 1 day | Broadhurst VanessaEVP, Global Corp Affairs | SSale | −23.1K | $251.27 | −$5.79M | −50.1%23.0K after | |
| Jun 12, 2026 (view filing) | Jun 11 | 1 day | Wengel Kathryn EEVP, Chief TO and Risk Officer | SSale | −10.0K | $241.15 | −$2.41M | −8.0%114.3K after | |
| Mar 3, 2026 (view filing) | Feb 27 | 4 days | Decker Robert JVP Corporate Controller | SSale | −4.08K | $247.87 | −$1.01M | −14.7%23.7K after | |
| Feb 23, 2026 (view filing) | Feb 20 | 3 days | Schmid TimothyEVP, WW Chair, MedTech | SSale | −1.32K | $245.66 | −$324.8K | −4.9%25.4K after | |
| Feb 18, 2026 (view filing) | Feb 13-17 | 5 days | Swanson James D.EVP, CIO | SSale | −62.1K | $243.39 | −$15.1M | −70.7%25.7K after | 3 lots |
Top 10 13F holders, Q2 2026
See all 4,720 holdersThe largest institutional positions in Johnson & Johnson at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 212,098,264 | $53.9B | 0.80% | −1,287,282−0.6% | Reduced |
| Vanguard Capital Management LLC | 157,226,374 | $39.9B | 0.85% | +621,004+0.4% | Added |
| State Street Corp | 133,776,025 | $34.0B | 1.00% | +299,737+0.2% | Added |
| Vanguard Portfolio Management LLC | 64,370,816 | $16.3B | 0.74% | +856,380+1.3% | Added |
| JPMorgan Chase & Co | 58,301,609 | $15.1B | 0.88% | −4,794,735−7.6% | Reduced |
| Geode Capital Management, LLC | 59,086,417 | $15.0B | 0.80% | −78,445−0.1% | Reduced |
| Morgan Stanley | 44,808,254 | $11.4B | 0.60% | +87,087+0.2% | Added |
| Norges Bank | 31,825,084 | $8.08B | 0.81% | +31,825,084 | New |
| State Farm Mutual Automobile Insurance Co | 31,590,952 | $8.02B | 5.49% | 00.0% | Unchanged |
| Northern Trust Corp | 28,792,064 | $7.31B | 0.85% | −527,605−1.8% | Reduced |
Holders of 5% or more of JNJ
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Johnson & Johnson.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 13G | 7.49%180.6M shares | New | May 1, 20261 filing | May 1, 2026 | SEC |
Politician trades
All politician trades in JNJ59 members of Congress reported 212 trades in Johnson & Johnson since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Oct 30, 2026 |  Thomas H. Kean, Jr. House · NJ | Sell (partial) | $1K-$15K |
| Oct 5, 2026 |  Lloyd Doggett House · TX | Buy | $1K-$15K |
| Sep 12, 2026 | Thomas H. Kean, Jr. House · NJ | Sell (partial) | $1K-$15K |
| Sep 11, 2026 |  John Boozman Senate · AR | Sell (partial) | $1K-$15K |
| Aug 14, 2026 |  Richard McCormick House · GA | Sell | $1K-$15K |
House · NJ · Oct 30, 2026
Sell (partial)$1K-$15K
House · TX · Oct 5, 2026
Buy$1K-$15K
House · NJ · Sep 12, 2026
Sell (partial)$1K-$15K
Senate · AR · Sep 11, 2026
Sell (partial)$1K-$15K
House · GA · Aug 14, 2026
Sell$1K-$15K